1. Home
  2. ELVN vs FBRT Comparison

ELVN vs FBRT Comparison

Compare ELVN & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • FBRT
  • Stock Information
  • Founded
  • ELVN 2016
  • FBRT 2012
  • Country
  • ELVN United States
  • FBRT United States
  • Employees
  • ELVN 63
  • FBRT N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • FBRT Real Estate Investment Trusts
  • Sector
  • ELVN Health Care
  • FBRT Real Estate
  • Exchange
  • ELVN Nasdaq
  • FBRT Nasdaq
  • Market Cap
  • ELVN 1.2B
  • FBRT 918.2M
  • IPO Year
  • ELVN 2020
  • FBRT 1985
  • Fundamental
  • Price
  • ELVN $19.79
  • FBRT $11.37
  • Analyst Decision
  • ELVN Strong Buy
  • FBRT Strong Buy
  • Analyst Count
  • ELVN 5
  • FBRT 5
  • Target Price
  • ELVN $41.20
  • FBRT $14.90
  • AVG Volume (30 Days)
  • ELVN 466.4K
  • FBRT 396.8K
  • Earning Date
  • ELVN 11-12-2025
  • FBRT 11-03-2025
  • Dividend Yield
  • ELVN N/A
  • FBRT 12.50%
  • EPS Growth
  • ELVN N/A
  • FBRT 18.52
  • EPS
  • ELVN N/A
  • FBRT 0.98
  • Revenue
  • ELVN N/A
  • FBRT $207,768,000.00
  • Revenue This Year
  • ELVN N/A
  • FBRT $28.21
  • Revenue Next Year
  • ELVN $25.00
  • FBRT $2.40
  • P/E Ratio
  • ELVN N/A
  • FBRT $11.59
  • Revenue Growth
  • ELVN N/A
  • FBRT 16.05
  • 52 Week Low
  • ELVN $13.30
  • FBRT $9.79
  • 52 Week High
  • ELVN $30.03
  • FBRT $13.74
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 47.83
  • FBRT 53.09
  • Support Level
  • ELVN $18.80
  • FBRT $11.58
  • Resistance Level
  • ELVN $21.30
  • FBRT $11.68
  • Average True Range (ATR)
  • ELVN 0.96
  • FBRT 0.17
  • MACD
  • ELVN -0.05
  • FBRT -0.03
  • Stochastic Oscillator
  • ELVN 39.40
  • FBRT 26.56

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About FBRT Franklin BSP Realty Trust Inc.

Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.

Share on Social Networks: